Abstract:Abstract Members of the NOD-like receptor (NLR) family play an important role in intestinal homeostasis. NLRP6, a NLR whose upstream agonist is not yet known, is highly expressed on the intestinal epithelium and certain immune cells. NLRP6 is an inflammasome that regulates IL-1β and IL-18 secretion. However, in contrast to other NLRs, it has also been shown to act as a regulator of intestinal inflammation and tumorigenesis either by alteration of gut microflora composition or through regulation macrophages and/ or the integrity of the epithelial barrier by goblet cells. Given its unique functions in GI tract, we determined its role in the severity of GI GVHD by testing the hypothesis that the absence of the NLRP6 would enhance GI GVHD severity. We utilized the well-characterized MHC disparate BALB/c→B6 model of GVHD. B6 wild type (WT) and B6 NLRP6-/- animals were lethally irradiated (11Gy) and transplanted with 5x106 BM and 3x106 splenic T-cells from either syngeneic WT-B6 or allogeneic BALB/c donors. Contrary to the hypothesis, allogeneic B6 NLRP6-/- animals showed significantly improved survival compared to the allo-B6 WT animals (p<0.01). The decrease in mortality was associated with reduced GVHD specific clinical severity and histopathology of the GI tract (p<0.05). Similar results were obtained in a MHC matched, minor disparate model. Despite the reduction in GVHD mortality and GI damage, donor T-cells demonstrated equivalent expansion and cytokine secretion (IFNγ, IL-17 and TNFα) in both allogeneic WT and NLRP6-/- animals (days 7, 14, and 21) both in the spleen and in the GI tract. Similar recruitment of donor derived monocytes in the gut (day21) was observed in both the allo-groups. The macrophages and the dendritic cells from the WT and NLRP6-/- B6 animals induced similar in vitro proliferation and cytokine secretion of the allogeneic BALB/c T-cells. To further specifically evaluate the role of host hematopoietic derived immune cells in vivo, we generated [B6→B6Ly5.2] and [NLRP6-/-B6→B6Ly5.2] chimeras (only the radiosensitive host hematopoietic cells are deficient for NLRP6) and utilized them as allogeneic recipients as above. Both the chimeras demonstrated similar severity and mortality. These data collectively demonstrate that the reduction in GI GVHD observed in the absence of NLRP6 in the host is unlikely due the direct effect on donor T-cells by the host hematopoietic derived cells. Next, to test whether the alteration in the microbiota associated with NLRP6 deficiency was critical for protection from GVHD, we co-housed the NLRP6-/- and WT B6 for 3 weeks and then utilized them as allo-recipients as above. Co-housed B6 NLRP6-/- animals still showed significantly improved survival and decreased GVHD severity when compared to WT B6 animals, suggesting that alteration of microbiota is dispensable for protection from GVHD. Because NLRP6 is highly expressed on the intestinal epithelium we next evaluated whether the reduction in GVHD is due to the absence of NLRP6 on the host non-hematopoietic cells such as the intestinal epithelial cells. To this end, we generated [B6→B6Ly5.2] [and [B6Ly5.2→NLRP6-/-] BM chimeras and utilized them as allo-recipients. The allogeneic [B6Ly5.2→NLRP6-/-] animals demonstrated significantly improved survival compared to the allogeneic [B6→B6Ly5.2] recipient animals (p<0.04). Furthermore, significantly less barrier permeability, determined by labeled dextran and greater staining of the LGR4+ intestinal cells was observed in the absence of NLRP6. These data indicate that the absence of NLRP6 in host non-hematopoietic cells, likely the intestinal epithelial cells, is critical for protection from GVHD. To establish the mechanism through which these results are observed, we hypothesized that the GVHD protection is due to greater resistance of the intestinal epithelial cells in NLRP6 -/- to apoptosis following allo-BMT. We isolated intestinal epithelial cells from WT and NLRP6-/- animals and determined the expression of pro- and anti-apoptotic genes. The expression of anti-apoptotic genes, Bcl and Bcl-XL was significantly increased without significant changes in the expression of pro-apoptotic genes in NLRP6-/- animals. These results demonstrate a novel role and mechanism through which NLRP6 contributes to the pathogenesis of GVHD and suggest that targeting NLRP6 could be a novel strategy to mitigate GVHD. Disclosures No relevant conflicts of interest to declare.

The Absence of Peyer’s Patches or Host TNF-A Does Not Affect GVHD Progression in an Allogeneic BMT Model Using Extensive Conditioning Regimens

Peyer Patches Are Not Required for Acute Graft-Versus-host Disease after Myeloablative Conditioning and Murine Allogeneic Bone Marrow Transplantation.

[Relationship of Tumor Necrosis Factor Gene Polymorphism and Acute Graft-Versus-host Disease after Unrelated Allogeneic Hematopoietic Stem Cell Transplantation].

Single-Cell Transcriptional Survey of the Initiation, Propagation and Maintenance of the Intestinal Graft-Versus-Host Disease

Genetic Variation In The Effector Pathways Of Cytotoxic T Lymphocytes Influences Alloimmune Reactivities Following Allogeneic Hematopoietic Stem Cell Transplantation

Dissociating GVT from GVHD in Murine BMT Models Through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.

NLRP6 Expression By the Hosts Enhances the Severity of Experimental Graft-Versus-Host Disease (GVHD)

Modulating the Conformation of the TIR Domain by a Neoteric MyD88 Inhibitor Leads to the Separation of GVHD from GVT.

Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease

[Experimental Study of Tripterygium Hypoglaucum (level) Hutch on Preventing Acute Graft-Versus-host Disease in Bone Marrow Transplantation Mice].

[Influence of Mouse Genetic Engineering Regulatory T Cells Infusion on Post-Allogeneic Bone Marrow Transplantation Acute Graft-Versus-host Disease in Mice].

IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-Versus-host Disease and Preserve Graft-Versus-tumor Responses after Allogeneic Bone Marrow Transplantation.

Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study

TNFα -238A Allele Identifies Patients Who Develop Both Acute and Chronic GVHD after Matched Unrelated Donor Transplant in Children: A Pediatric Blood and Marrow Transplant Consortium Study

The Absence of IL-12Rβ2 Expression on Recipient Nonhematopoietic Cells Diminishes Acute Graft-versus-Host Disease in the Gastrointestinal Tract

Induction of acute graft vs. host disease in lymphopenic mice

TCF-1is Required By CD8 + T Cells for the Maintenance of Alloimmune Responses in Graft-Vs-Host Disease

An Absence of CCR5 on Donor Cells Results in Acceleration of Acute Graft-Vs-host Disease.

382: Β2 Intergrins Separates Graft-versus-host Disease and Graft-versus-leukemia Effect

Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction

Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice